|

Meet the Legal Risk Report: AI That Accelerates Transaction Due Diligence

Following the success of SESAMm’s AI-Powered Deal Screening Reports, we’re expanding our due diligence suite with a new...

Controversial Business Involvement Screening Challenges: Public vs. Private Markets

Screening a portfolio for controversial business involvement is fundamentally different in public markets than in...

|

The ESG Scorecard: A Deep Dive into the Pharmaceutical Industry

There’s no denying that ESG risk exposure in the pharmaceutical industry is high. This stems from the intense...

|

Nathalie Wallace Joins SESAMm Advisory, Bringing Senior Investment Expertise

SESAMm is pleased to announce that Nathalie Wallace is joining our Advisory Board. Nathalie brings more than 20 years...

| |

A Clearer View of Risk: A New Year's Message from SESAMm

As 2026 kicks off, I want to take a moment to reflect on the year we’ve just closed. 2025 was an important year for...

SFDR 2.0: A Reset for Sustainable Fund Classification

The Sustainable Finance Disclosure Regulation (SFDR) is the EU’s framework for governing how sustainability...

|

The ESG Scorecard: A Deep Dive into The Biotech Industry

The biotech industry faces significant ESG risks, particularly in governance. Social and operational risks are less...

|

November’s Fundamental Human Rights Controversies: A Market Analysis

Human rights concerns took center stage in November, with rising scrutiny on how digital platforms and luxury brands...

|

When Markets Move at Machine Speed: Why Corporate Crisis Response Must Evolve

When Meta's market value declined by $307 billion over four trading days in October 2025, it demonstrated a fundamental...